Exicure Announces Preclinical Data Supporting Development of SNA Technology in the Central Nervous System
Conference call scheduled for 8:00 am ET on June 27, 2019 CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc. (OTCQB: XCUR), a…
Pharmaceuticals, Biotechnology and Life Sciences
Conference call scheduled for 8:00 am ET on June 27, 2019 CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc. (OTCQB: XCUR), a…
U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) voted to recommend HPV vaccination with GARDASIL
ROSEVILLE, Minn.–(BUSINESS WIRE)–#Cdiff–Rebiotix, Inc, a Ferring Pharmaceuticals company, announced today that two members of their senior leadership team, Dr. Ken…
DUBLIN–(BUSINESS WIRE)–The “Biopharmaceutical CMO & CRO Market Size Analysis Report By Source, By Service Type (Contract Manufacturing, Contract Research), By…
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Sjögren’s Syndrome” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Sjogren’s…
DUBLIN–(BUSINESS WIRE)–The “Cabometyx” report has been added to ResearchAndMarkets.com’s offering. Cabometyx (cabozantinib; Exelixis/Ipsen/Takeda) is an orally available small molecule inhibitor…
BOULDER, Colo.–(BUSINESS WIRE)–PanTheryx, a biotechnology company focused on addressing serious GI related health conditions, announced today that it has completed…
— Modified Subscription Arrangement Reflects Shared Commitment to Significantly Increase Access to Hepatitis C Cures in Louisiana; State’s Goal is…
— Modified Subscription Arrangement Reflects Shared Commitment to Significantly Increase Access to Hepatitis C Cures in Louisiana; State’s Goal is…
DUBLIN–(BUSINESS WIRE)–The “Betalutin” report has been added to ResearchAndMarkets.com’s offering. Betalutin is a first-in-class antibody-radionucleotide conjugate targeted to CD37, an…